Metelimumab Antibody
Metelimumab (CAT-192) is a humanized monoclonal antibody designed to neutralize TGFβ1. It serves as a key research tool for investigating the pathogenesis and potential treatment strategies for diffuse systemic sclerosis (d-SSc) in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
CAT192, CAT-192, Anti-TGFB1 Recombinant Antibody
Target
TGF-beta/Smad
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Stem Cell & Developmental Biology
Concentration
15.745 mg/mL
Purity
≥95% (May vary between batches)
Molecular Weight
~150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx346688-01 20 µg
CREB-regulated transcription coactivator 3 (CRTC3) Antibody (HRP)
Sign In for Pricing
View Details abx346688-02 50 µg
CREB-regulated transcription coactivator 3 (CRTC3) Antibody (HRP)
Sign In for Pricing
View Details abx346688-03 100 µg
CREB-regulated transcription coactivator 3 (CRTC3) Antibody (HRP)
Sign In for Pricing
View Details